GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (WBO:ZBH) » Definitions » Other Operating Expense

Zimmer Biomet Holdings (WBO:ZBH) Other Operating Expense : €521 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Zimmer Biomet Holdings Other Operating Expense?

Zimmer Biomet Holdings's Other Operating Expense for the three months ended in Dec. 2023 was €133 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €521 Mil.

Zimmer Biomet Holdings's quarterly Other Operating Expense increased from Jun. 2023 (€128 Mil) to Sep. 2023 (€136 Mil) but then declined from Sep. 2023 (€136 Mil) to Dec. 2023 (€133 Mil).

Zimmer Biomet Holdings's annual Other Operating Expense increased from Dec. 2021 (€515 Mil) to Dec. 2022 (€529 Mil) but then declined from Dec. 2022 (€529 Mil) to Dec. 2023 (€515 Mil).


Zimmer Biomet Holdings Other Operating Expense Historical Data

The historical data trend for Zimmer Biomet Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Other Operating Expense Chart

Zimmer Biomet Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 600.03 462.79 515.34 529.21 514.90

Zimmer Biomet Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.90 124.60 127.56 135.87 132.87

Zimmer Biomet Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €521 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zimmer Biomet Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Zimmer Biomet Holdings (WBO:ZBH) Business Description

Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.